CVS Health Corp (NYSE:CVS)
| 94.92 Delayed Data As of May 20 |  +1.78 / +1.91%Today’s Change | 79.33 Today|||52-Week Range 111.25 | -7.99% Year-to-Date |
Latest CVS News | Press Releases
Today’s Trading
| Previous close | 93.14 |
| Today’s open | 93.42 |
| Day’s range | 92.76 - 95.21 |
| Volume | 5,194,154 |
| Average volume (3 months) | 6,335,934 |
| Market cap | $127.8B |
Data as of 4:05pm ET, 05/20/2022
Growth & Valuation
| Earnings growth (last year) | +9.35% |
| Earnings growth (this year) | -93.71% |
| Earnings growth (next 5 years) | +7.00% |
| Revenue growth (last year) | +8.67% |
| P/E ratio | 15.8 |
| Price/Sales | 0.47 |
| Price/Book | 1.72 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| WBAWalgreen | +0.34 | +0.84% |
| ---- | ||
| PETSPetmed Express Inc | -0.22 | -1.09% |
| RADRite Aid Corp | -0.01 | -0.18% |
Data as of 4:05pm ET, 05/20/2022
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | $2.18 |
| Annual revenue (last year) | $291.9B |
| Annual profit (last year) | $7.9B |
| Net profit margin | 2.71% |
Profile
Sector Retail Trade |
Industry Drugstore Chains |
No executives to display |
Corporate headquarters Woonsocket, Rhode Island |
Forecasts
